[Ip-health] IGWG II: Limitation on Diseases

[Pharmacy Policy Coordinator MOH Suriname]

--
[ Picked text/plain from multipart/alternative ]
judith, this is not the case

miriam


On 07/11/2007, Judit Rius Sanjuan <judit.rius@keionline.org> wrote:
>
> We have been informed that yesterday night one of the drafting group
> agreed to eliminate the footnote 1 included in the Secretariat Draft
> Global Strategy and Plan of Action.
>
> These are very good news because the footnote 1 included a unjustifiable
> limitation by listing the diseases that will be the focus of this global
> strategy and plan of action:
>
> Footnote eliminated: "The Commission's definitions of Type I, Type II
> and Type III diseases, and the specific diseases on which this draft
> strategy focuses, are as follows: Type I diseases are incident in both
> rich and poor countries, with large numbers of vulnerable populations in
> each. The strategy will focus on the following Type I diseases,
> increasingly prevalent in developing countries: diabetes, cardiovascular
> disease and cancer. Type II diseases are incident in both rich and poor
> countries, but with a substantial proportion of the cases in poor
> countries. For the purposes of the strategy, the focus is on HIV/AIDS
> and tuberculosis. Type III diseases are those that are overwhelmingly or
> exclusively incident in developing countries. For the purposes of the
> strategy, the focus is on the nine neglected infectious diseases that
> disproportionately affect poor and marginalized populations prioritized
> by the UNICEF/UNDP/World Bank/WHO Special Programme for Research and
> Training in Tropical Diseases: Chagas disease, dengue and dengue
> haemorrhagic fever, leishmaniasis, leprosy, lymphatic filariasis,
> malaria, onchocerciasis, schistosomiasis and human African
> trypanosomiasis."
>
> --
> Judit Rius Sanjuan
> Attorney
> judit.rius@keionline.org
>
> Knowledge Ecology International (KEI)
> www.keionline.org / www.cptech.org
> 1621 Connecticut Ave, NW, Suite 500 Washington, DC 20009 USA
> Tel.: +1.202.332.2670, Ext 18  Fax: +1.202.332.2673
>
> _______________________________________________
> Ip-health mailing list
> Ip-health@lists.essential.org
> http://lists.essential.org/mailman/listinfo/ip-health
>



--
Miriam Naarendorp MSc, RPh
Pharmacy Policy Coordinator
Ministry of Health Suriname
Henck Arronstraat
Paramaribo
Suriname
tel: +597-410441/ 420203 ext 299
fax:+597-473923
website: http://www.volksgezondheid.gov.sr/